Variability in abciximab (ReoPro) prescribing: evidence based or budget driven

J.E.F. Zwart - van Rijkom; H.G.M. Leufkens; M.L. Simoons; A.W. Broekmans

Variability in abciximab (ReoPro) prescribing: evidence based or budget driven

J.E.F. Zwart - van Rijkom
, H.G.M. Leufkens
, M.L. Simoons
, A.W. Broekmans

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	135-141
Number of pages	7
Journal	Drug Safety
Volume	11
Issue number	2
Publication status	Published - 2002

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Zwart 02 variabilityinabciximab
Open Access (free)
Final published version, 94.2 KB

Cite this

@article{597fbfe1d28c44e597b48f4fded946f2,

title = "Variability in abciximab (ReoPro) prescribing: evidence based or budget driven",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "\{Zwart - van Rijkom\}, J.E.F. and H.G.M. Leufkens and M.L. Simoons and A.W. Broekmans",

year = "2002",

language = "Undefined/Unknown",

volume = "11",

pages = "135--141",

journal = "Drug Safety",

issn = "0114-5916",

publisher = "Adis",

number = "2",

}

TY - JOUR

T1 - Variability in abciximab (ReoPro) prescribing: evidence based or budget driven

AU - Zwart - van Rijkom, J.E.F.

AU - Leufkens, H.G.M.

AU - Simoons, M.L.

AU - Broekmans, A.W.

PY - 2002

Y1 - 2002

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 0114-5916

VL - 11

SP - 135

EP - 141

JO - Drug Safety

JF - Drug Safety

IS - 2

ER -